Search

Zai Lab Ltd ADR

Uždarymo kaina

SektoriusSveikatos priežiūra

26.07 -2.76

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

25.73

Max

26.78

Pagrindiniai rodikliai

By Trading Economics

Pajamos

191K

-51M

Pardavimai

6.7M

106M

Pelnas, tenkantis vienai akcijai

-0.46

Pelno marža

-47.808

Darbuotojai

1,784

EBITDA

-2.1M

-46M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+46.64% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

826M

2.9B

Ankstesnė atidarymo kaina

28.83

Ankstesnė uždarymo kaina

26.07

Naujienos nuotaikos

By Acuity

50%

50%

126 / 340 reitingas Healthcare

Zai Lab Ltd ADR Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-28 23:56; UTC

News

nVent Electric PLC will acquire Maverick Power for $1.75 billion, with additional performance-based payments. Shares are higher during after-market hours following the announcement.

2026-08-28 23:46; UTC

News

Diamondback Energy shares declined after-market, despite earlier gains, amid rising market expectations for a rate hike and increased Treasury yields.

2026-08-28 23:46; UTC

News

Target Corp filed for a mixed securities shelf and registered 15.5 million shares under its employee incentive plan. Shares remained roughly flat in after-market hours.

2026-08-28 23:41; UTC

News

Blue Owl Capital gained in after-market trading after leading a $2.4 billion financing deal for Iren Ltd. to purchase Nvidia Blackwell Ultra GPUs.

2026-08-28 23:41; UTC

News

Group 1 Automotive Inc shares declined in after-market hours, pressured by ratings downgrades from Barclays PLC and Weiss Ratings amid rising Treasury yields.

2026-08-28 23:21; UTC

News

Incyte Corp shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down amid rising Treasury yields and mixed ESMO data sentiment.

2026-08-28 23:21; UTC

News

Intuit Inc. shares are trading lower in after-market hours following a class action lawsuit alleging misleading statements about its financial performance and competitive advantages.

2026-08-28 23:06; UTC

News

Coherus Oncology's $50 million common share offering pressures shares lower in after-market trading, marking a pullback from recent highs.

2026-08-28 23:06; UTC

News

BioNTech SE shares are higher in after-market trading, supported by a Strong Buy rating and a cash position of $19.28 billion for R&D efforts.

2026-08-28 23:06; UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate expectations and geopolitical tensions impact investor confidence.

2026-08-28 23:06; UTC

Macro Event
News

Bitcoin is trading lower as hawkish comments from Federal Reserve Chairman Kevin Warsh raise interest rate hike expectations and geopolitical tensions impact market confidence.

2026-08-28 23:06; UTC

News

Lowe's Companies declared a quarterly cash dividend of $1.25 per share, boosting shares in after-market trading following the announcement.

2026-08-28 23:06; UTC

News

Visa Inc shares are higher in after-market trading following a partnership with Dunamu to develop stablecoin payments and cross-border remittance services.

2026-08-28 23:06; UTC

News

Michael Burry has reduced his stake in PayPal as acquisition talks with Advent International and Stripe have ended. Shares are slightly higher in after-hours trading.

2026-08-28 23:02; UTC

News

Halliburton Co is positioned for multi-billion-dollar deals in Venezuelan crude reserves, contributing to higher shares in after-market hours.

2026-08-28 23:01; UTC

News

Pinterest Inc shares declined in after-market trading following the resignation announcement of CFO Julia Brau Donnelly, effective October 30, 2026. Trading remains weak overall.

2026-08-28 23:01; UTC

News

Chemours Co faces an investigation by Pomerantz LLP over potential securities law violations. Shares are trading higher in after-market hours despite concerns over internal controls.

2026-08-28 23:01; UTC

News

Alnylam Pharmaceuticals shares rose in after-market hours, despite concerns from a failed cardiomyopathy trial. The company's market capitalization stands at $31.57 billion.

2026-08-28 23:01; UTC

News

Flowers Foods shares are lower in after-market trading following the filing of a mixed securities shelf, raising potential concerns about dilution and financial strategy.

2026-08-28 23:01; UTC

Event
News

Eli Lilly's shares rise in after-market trading following FDA approval of Mounjaro for reducing cardiovascular risks in type 2 diabetes patients.

2026-08-28 23:01; UTC

News

Chevron is nearing multi-billion-dollar deals to expand operations in Venezuela, targeting two heavy-oil fields. Shares are trading higher in after-market hours.

2026-08-28 23:01; UTC

News

McKesson Corp disclosed a cybersecurity incident affecting its information systems, with shares trading lower in after-market hours amid broader market weakness.

2026-08-28 23:01; UTC

News

Vistra Corp reported gross revenue of $17.74 billion and net income of $944 million. Shares are higher in after-market trading following the earnings release.

2026-08-28 23:01; UTC

News

Planet Fitness Inc shares declined in after-market trading following a class action lawsuit alleging misleading investor information about customer metrics and reduced growth guidance.

2026-08-28 21:01; UTC

News

Hyatt Hotels filed a mixed shelf registration, seen as potentially dilutive. Shares are trading lower in after-market hours, continuing a recent decline.

2026-08-28 20:52; UTC

News
Correlated Moves

Silver prices are declining amid negative sentiment in precious metals. Remarks from Federal Reserve Chair Warsh and weak consumer sentiment contribute to the drop.

2026-08-28 20:52; UTC

Correlated Moves
News

Silver/JPY is trading lower amid negative sentiment in precious metals following Federal Reserve comments on potential rate increases and a decline in consumer sentiment.

2026-08-28 20:52; UTC

Correlated Moves
News

Silver is trading lower as negative sentiment in precious metals grows after comments from Federal Reserve Chair Kevin Warsh regarding potential rate increases.

2026-08-28 20:52; UTC

Correlated Moves
News

Silver Ounce vs Euro is lower amid negative sentiment in precious metals following Federal Reserve remarks and a significant decline in the Michigan Consumer Sentiment index.

2026-08-28 20:52; UTC

Correlated Moves
News

Silver prices are lower amid negative sentiment from Federal Reserve remarks and a decline in the Michigan Consumer Sentiment index. The asset remains volatile.

Akcijų palyginimas

Kainos pokytis

Zai Lab Ltd ADR Prognozė

Kainos tikslas

By TipRanks

46.64% į viršų

12 mėnesių prognozė

Vidutinis 39.33 USD  46.64%

Aukščiausias 45 USD

Žemiausias 36 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Zai Lab Ltd ADR kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

126 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat